Wherrett, Diane K
$5,999,552.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- June 1, 2023 – May 31, 2027
- Reference
- cihr-irsc:236-2023-2024-Q1-00742
Published purpose
The specific objectives of this funding opportunity are to: • Establish an interdisciplinary, inter-jurisdictional, and inter-sectoral National Type 1 Diabetes (T1D) Screening Research Consortium that aims to investigate the feasibility of T1D screening in the general population in Canada, building on the successes and experiences from other countries. • Develop, implement, and evaluate research relevant to T1D screening that generates evidence to increase opportunities to identify pre-symptomatic T1D in the Canadian pediatric population, reduce the incidence of DKA at diagnosis, and improve outcomes for children and youth diagnosed with T1D, and their families. • Support research that involves meaningful engagement with diverse stakeholders and PWLE, with particular attention to health disparities, Canada’s diverse ethnocultural population and Indigenous Peoples' health and well-being. • Build Canadian research capacity in the area of T1D screening. • Maximize research impact and knowledge mobilization to inform health policy, decision making and planning; this includes the ethical, economic, legal and social aspects of T1D screening in the general population.
In plain English AI-generated
This grant funds a national consortium to research the feasibility of screening for Type 1 Diabetes in the general Canadian pediatric population, aiming to reduce diagnosis complications and improve outcomes for children and youth.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.